CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

AMERICAN JOURNAL OF NEURORADIOLOGY, published by the American Society of Neuroradiology, is a premier peer-reviewed journal dedicated to advancing the field of neuroradiology. With an ISSN of 0195-6108 and an E-ISSN of 1936-959X, the journal serves as a vital resource for clinicians, researchers, and students in the realms of neurology and radiology. With a commendable Q1 ranking in multiple categories including Medicine (Miscellaneous), Clinical Neurology, and Radiology, Nuclear Medicine and Imaging, it remains at the forefront of scholarly communication since its inception in 1980. The journal enjoys significant visibility, ranked #47 out of 333 in radiology and #81 out of 400 in clinical neurology, highlighting its impact within these competitive fields. Although it is not open access, AMERICAN JOURNAL OF NEURORADIOLOGY is committed to publishing innovative research that enhances clinical practice and informs neurological imaging techniques, making it an essential read for anyone involved in the advanced study of neuroradiology.

Multiple Sclerosis Journal, published by SAGE Publications Ltd, is a leading academic journal in the fields of neurology and clinical neurology, with an impressive impact factor reflecting its critical role in neurological research. Established in 1995 and continuing to 2024, this journal has positioned itself as a premier platform for disseminating innovative and impactful research related to multiple sclerosis, thereby contributing significantly to both clinical practice and scientific advancements in the field. The journal's robust standing is evidenced by its Q1 category rankings, placing it in the top tier of both Neuroscience (Rank #16/192, 91st Percentile) and Clinical Neurology (Rank #35/400, 91st Percentile) categories, making it an essential resource for researchers, healthcare professionals, and students alike. The journal focuses on a wide array of topics, including basic research, clinical trials, and treatment methodologies, ensuring that its readership is well-informed about the latest developments and trends. Access to its articles is through subscription, fostering a reputable environment for quality research dissemination.

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Physical Medicine and Rehabilitation Clinics of North America is a leading journal published by W B Saunders Co-Elsevier Inc., focusing on the multifaceted disciplines of physical medicine, rehabilitation, and related health professions. With an impressive impact factor reflecting its significant contribution to the field, this journal ranks in the Q2 quartile for both Physical Therapy and Rehabilitation categories. The journal, available in both print (ISSN: 1047-9651) and online (E-ISSN: 1558-1381), provides critical insights, clinical updates, and comprehensive reviews that are essential for researchers, practitioners, and students alike. Covering a wide spectrum of topics from innovative rehabilitation techniques to emerging trends in sports medicine, it aims to disseminate knowledge that enhances patient care and drives advancements in rehabilitation practices. With a publication history spanning from 1995 to 2024, Physical Medicine and Rehabilitation Clinics is an essential resource for those dedicated to improving functional outcomes and the quality of life for patients worldwide.

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

Journal of Stroke & Cerebrovascular Diseases, published by ELSEVIER, is a leading international peer-reviewed journal dedicated to advancing the research and understanding of stroke and cerebrovascular disorders. With an impressive impact factor reflective of its rigorous academic standards, this journal is indexed in the highest echelons of medical disciplines, boasting a Q1 classification in Rehabilitation and prominent rankings in related fields. Established in 1991 and converging its focus toward 2024, it serves as a vital resource for researchers and clinicians interested in the complexities and treatment of cerebrovascular conditions. The journal's broad scope spans essential categories such as cardiology, neurology, and surgery, making significant contributions that enhance clinical practices and patient outcomes. For researchers, professionals, and students alike, the Journal of Stroke & Cerebrovascular Diseases is not just a publication but a critical platform for sharing innovative findings and fostering impactful discussions within the medical community.

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.